vectibix.fi
Amgen AB Finland
Keilaranta 16
02150 Espoo
FI
02150 Espoo
FI
Y-tunnus: 1090790-9
Puh:
Puh:
Lähde: Traficom
Siirry verkkotunnukseen
Verkkotunnus on ONLINE (ping: 246 ms)
Vectibix.fi on rekisteröity 19 vuotta sitten. Verkkotunnuksen haltija on Amgen AB Finland ja välittäjänä toimii MarkMonitor Inc..
Verkkotunnuksen rekisteröintitiedot
Rekisteröity:
18.10.2005
Päättyy:
18.10.2025
Vapautuu:
18.11.2025
Tila:
Registered
Välittäjä:
MarkMonitor Inc.
Palvelimen IP:
44.236.55.75
Nimipalvelimet:
ns-1223.awsdns-24.org
ns-1577.awsdns-05.co.uk
ns-307.awsdns-38.com
ns-602.awsdns-11.net
ns-1577.awsdns-05.co.uk
ns-307.awsdns-38.com
ns-602.awsdns-11.net
Haltijan muut verkkotunnukset (19)
Verkkotunnus
Rekisteröity:
SEO raportti
Otsikko
Amgen | A Worldwide Pioneer in Biotechnology
Kuvaus
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
H1 Otsikot (1)
- Amgen | A Worldwide Pioneer in Biotechnology
H2 Otsikot (21)
- Ten Years of BLINCYTO® (blinatumomab): Celebrating the History, Impact and Future
- Amgen's Nobel Laureate Network: A Catalyst for Innovation
- A Fight for Hope: Inspiring Others Through Childhood B-ALL
- New Apprentice Program Draws Talent from Unexpected Sources
- Amgen Announces Robust Weight Loss With MariTide in People Living With Obesity or Overweight in Phase 2 Study
- Reflecting on Two Patients' Perseverance and Strength During Lung Cancer Awareness Month
- A Journey of Courage: Empowering Others with Gastric Cancer
- Understanding Cardiovascular Risk: The Role of LDL-C, Comorbidities and Early Intervention
- Army Veteran Mike Berke Helping Lead the Charge in Research Automation
- Championing Quality Every Day
- Collaboration and Community Engagement: Two Powerful Ways to Improve Health
- Amgen Announces 2024 Third Quarter Financial Results
- Actress and Producer La La Anthony Gets Personal About Her Plaque Psoriasis Journey
- Sandra Rodriguez-Toledo, Vice President, Site Operations at Amgen Ohio, Inducted Into Women in Manufacturing Hall of Fame
- Championing Inclusivity During National Disability Employment Awareness Month
- Our Story
- Our Science
- Our Products
- Our Responsibility
- Amgen Investors
- Careers With Amgen
H3 Otsikot (2)
- Our Latest Press Releases
- Follow Us On Social Media
H4 Otsikot (0)
H5 Otsikot (2)
- Global hotline for Ukrainian refugee patients participating in an Amgen clinical trial.
- Click here for more information.
H6 Otsikot (0)